Champions Oncology Ownership | Who Owns Champions Oncology?

Overview Forecast RevenueFinancials Chart Transcripts

Champions Oncology Ownership Summary

Champions Oncology is owned by 43.19% institutional investors, 25.85% insiders, and 30.96% retail investors. Battery management is the largest institutional shareholder, holding 17.81% of CSBR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.70% of its assets in Champions Oncology shares.

CSBR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Champions Oncology	43.19%	25.85%	30.96%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Battery management	2.42M	17.81%	$20.75M
Nea management company	1.71M	12.61%	$14.69M
Tocqueville asset management	608.91K	4.48%	$5.22M
Vanguard group	307.00K	2.26%	$2.63M
Renaissance	138.84K	1.02%	$1.19M
Blackrock funding, inc. /de	116.30K	0.86%	$996.69K
Blackrock	116.07K	0.85%	$600.09K
Geode capital management	66.51K	0.49%	$570.16K
Morgan stanley	43.10K	0.32%	$222.83K
Northern trust	40.46K	0.30%	$209.19K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Battery management	2.42M	2.66%	$20.75M
Nea management company	1.71M	0.83%	$14.69M
Tocqueville asset management	608.91K	0.08%	$5.22M
Mesirow financial investment management	12.00K	0.00%	$102.84K
Renaissance	138.84K	0.00%	$1.19M
Acadian asset management	30.70K	0.00%	$261.00K
Hightower advisors	39.31K	0.00%	$336.87K
Cambridge investment research advisors	12.25K	0.00%	$105.00K
Tower research capital llc (trc)	1.64K	0.00%	$14.05K
Stifel financial	10.94K	0.00%	$56.57K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	138.84K	0.00%	18.85K
Susquehanna group, llp	11.52K	-	11.52K
Morgan stanley	43.10K	-	2.40K
Geode capital management	66.51K	-	1.45K
Simplex trading	3.00K	-	1.41K

Top Sellers

Holder	Shares	% Assets	Change
Tocqueville asset management	608.91K	0.08%	-96.30K
Essex investment management	-	-	-77.20K
Goldman sachs group	-	-	-48.41K
Virtu financial	-	-	-11.05K
Northern trust	40.46K	-	-2.23K

New Positions

Holder	Shares	% Assets	Change	Value
Susquehanna group, llp	11.52K	-	11.52K	$98.76K

Sold Out

Holder	Change
Wells fargo & company/mn	-47.00
Ubs group	-1.28K
Virtu financial	-11.05K
Goldman sachs group	-48.41K
Essex investment management	-77.20K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	36	38.46%	5,917,321	3.47%	43	2.44%	21	110.00%	6	100.00%
Dec 31, 2024	26	18.18%	5,718,724	-1.12%	42	2.32%	10	-9.09%	3	50.00%
Sep 30, 2024	22	-12.00%	5,783,612	0.16%	42	2.36%	11	57.14%	2	-71.43%
Jun 30, 2024	25	-3.85%	5,774,158	2.50%	42	2.47%	7	-36.36%	7	-12.50%
Mar 31, 2024	26	-3.70%	5,633,547	0.38%	41	2.40%	11	57.14%	8	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	235.74K	1.70%	-
Vanguard Total Stock Mkt Idx Inv	235.74K	1.70%	-
IMC US Ultra Micro Cap	88.31K	0.64%	-
Vanguard Institutional Extnd Mkt Idx Tr	82.67K	0.60%	12.63K
Pleiades Small Cap Equity A	44.16K	0.32%	44.16K
Fidelity Extended Market Index	32.99K	0.24%	129.00
iShares Micro-Cap ETF	14.22K	0.10%	-
Fidelity Total Market Index	12.24K	0.09%	-
BlackRock Extended Equity Market K	11.17K	0.08%	-5.00
Extended Equity Market Fund K	11.05K	0.08%	34.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 12, 2024	Mendelson Daniel Newman	-	Buy	$6.50K
Jan 11, 2024	Mendelson Daniel Newman	-	Buy	$12.54K
Jan 10, 2024	Mendelson Daniel Newman	-	Buy	$18.58K
Jan 09, 2024	Mendelson Daniel Newman	-	Buy	$18.75K
Jan 08, 2024	Mendelson Daniel Newman	-	Buy	$6.15K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q1	8	-
2023 Q4	9	-
2023 Q3	8	-
2023 Q1	1	-

CSBR Ownership FAQ

Who Owns Champions Oncology?

Champions Oncology shareholders are primarily institutional investors at 43.19%, followed by 25.85% insiders and 30.96% retail investors. The average institutional ownership in Champions Oncology's industry, Biotech Stocks , is 63.96%, which Champions Oncology falls below.

Who owns the most shares of Champions Oncology?

Champions Oncology’s largest shareholders are Battery management (2.42M shares, 17.81%), Nea management company (1.71M shares, 12.61%), and Tocqueville asset management (608.92K shares, 4.48%). Together, they hold 34.90% of Champions Oncology’s total shares outstanding.

Does Blackrock own Champions Oncology?

Yes, BlackRock owns 0.85% of Champions Oncology, totaling 116.07K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 600.09K$. In the last quarter, BlackRock increased its holdings by 389 shares, a 0.34% change.

Who is Champions Oncology’s biggest shareholder by percentage of total assets invested?

Battery management is Champions Oncology’s biggest shareholder by percentage of total assets invested, with 2.66% of its assets in 2.42M Champions Oncology shares, valued at 20.75M$.

Who is the top mutual fund holder of Champions Oncology shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Champions Oncology shares, with 1.70% of its total shares outstanding invested in 235.74K Champions Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools